Terms: = Bone cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Clinical Outcome
65 results:
1. [The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies].
Hu SS; Wu YB; Zhu PP; Shi JM; Yu J; Zhao YM; Lai XY; Liu LZ; Fu HR; Huang H; Luo Y
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):992-1002. PubMed ID: 36709104
[No Abstract] [Full Text] [Related]
2. Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic Transplantation.
Schwarzbich MA; Dai H; Kordelas L; Beelen DW; Radujkovic A; Müller-Tidow C; Dreger P; Luft T
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216457
[TBL] [Abstract] [Full Text] [Related]
3. Identification of immune subtypes of Ph-neg B-ALL with ferroptosis related genes and the potential implementation of Sorafenib.
Hong Y; Zhang L; Tian X; Xiang X; Yu Y; Zeng Z; Cao Y; Chen S; Sun A
BMC Cancer; 2021 Dec; 21(1):1331. PubMed ID: 34906116
[TBL] [Abstract] [Full Text] [Related]
4. Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data.
Badar T; Szabo A; Litzow M; Burkart M; Yurkiewicz I; Dinner S; Hefazi M; Shallis RM; Podoltsev N; Patel AA; Curran E; Wadleigh M; Balasubramanian S; Yang J; Arslan S; Aldoss I; Mattison R; Cenin D; Siebenaller C; Advani A; Liedtke M; Atallah E
Bone Marrow Transplant; 2021 Aug; 56(8):1998-2004. PubMed ID: 33824440
[TBL] [Abstract] [Full Text] [Related]
5. clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the bone Marrow Pathology Group.
Weinberg OK; Chisholm KM; Ok CY; Fedoriw Y; Grzywacz B; Kurzer JH; Mason EF; Moser KA; Bhattacharya S; Xu M; Babu D; Foucar K; Tam W; Bagg A; Orazi A; George TI; Wang W; Wang SA; Arber DA; Hasserjian RP
Mod Pathol; 2021 Jul; 34(7):1358-1366. PubMed ID: 33526873
[TBL] [Abstract] [Full Text] [Related]
6. BACH2-mediated FOS confers cytarabine resistance via stromal microenvironment alterations in pediatric ALL.
Zhang H; Zhang R; Zheng X; Sun M; Fan J; Fang C; Tian X; Zheng H
Cancer Sci; 2021 Mar; 112(3):1235-1250. PubMed ID: 33393145
[TBL] [Abstract] [Full Text] [Related]
7. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
[TBL] [Abstract] [Full Text] [Related]
8. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.
Morabito F; Gentile M; Monti P; Recchia AG; Menichini P; Skafi M; Atrash M; De Luca G; Bossio S; Al-Janazreh H; Galimberti S; Salah Z; Morabito L; Mujahed A; Hindiyeh M; Dono M; Fais F; Cutrona G; Neri A; Tripepi G; Fronza G; Ferrarini M
Expert Opin Investig Drugs; 2020 Aug; 29(8):869-880. PubMed ID: 32551999
[TBL] [Abstract] [Full Text] [Related]
9. Suppression of Musashi‑2 by the small compound largazole exerts inhibitory effects on malignant cells.
Wang M; Sun XY; Zhou YC; Zhang KJ; Lu YZ; Liu J; Huang YC; Wang GZ; Jiang S; Zhou GB
Int J Oncol; 2020 May; 56(5):1274-1283. PubMed ID: 32319553
[TBL] [Abstract] [Full Text] [Related]
10. Treatment of Metastatic or High-Risk Solid cancer Patients by Targeting the Immune System and/or Tumor Burden: Six Cases Reports.
Nicolini A; Ferrari P; Morganti R; Carpi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795079
[TBL] [Abstract] [Full Text] [Related]
11. Impact of early chimerism status on clinical outcome in children with acute lymphoblastic leukaemia after haematopoietic stem cell transplantation.
Lejman M; Zaucha-Prażmo A; Zawitkowska J; Mroczkowska A; Grabowski D; Kowalczyk JR; Drabko K
BMC Cancer; 2019 Nov; 19(1):1141. PubMed ID: 31771553
[TBL] [Abstract] [Full Text] [Related]
12. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor.
Das N; Thakral D; Singh G; Malhotra A; Phulware RH; Gogia A; Gupta R
Indian J Pathol Microbiol; 2019; 62(4):614-617. PubMed ID: 31611454
[TBL] [Abstract] [Full Text] [Related]
13. The
Pansy K; Feichtinger J; Ehall B; Uhl B; Sedej M; Roula D; Pursche B; Wolf A; Zoidl M; Steinbauer E; Gruber V; Greinix HT; Prochazka KT; Thallinger GG; Heinemann A; Beham-Schmid C; Neumeister P; Wrodnigg TM; Fechter K; Deutsch AJ
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554271
[TBL] [Abstract] [Full Text] [Related]
14. Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish cml registry.
Lübking A; Dreimane A; Sandin F; Isaksson C; Märkevärn B; Brune M; Ljungman P; Lenhoff S; Stenke L; Höglund M; Richter J; Olsson-Strömberg U
Bone Marrow Transplant; 2019 Nov; 54(11):1764-1774. PubMed ID: 30962502
[TBL] [Abstract] [Full Text] [Related]
15. Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive cml patient undergoing treatment with dasatinib.
Janjetovic S; Asemissen AM; Dicker F; Binder M; Dierlamm J; Bokemeyer C; Schafhausen P
Tumori; 2019 Dec; 105(6):NP8-NP11. PubMed ID: 30935343
[TBL] [Abstract] [Full Text] [Related]
16. Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
Zovko A; Yektaei-Karin E; Salamon D; Nilsson A; Wallvik J; Stenke L
Oncol Rep; 2018 Aug; 40(2):902-908. PubMed ID: 29845257
[TBL] [Abstract] [Full Text] [Related]
17. [Donor chimerism and minimal residual disease monitoring in leukemia patients after allo-HSCT].
Bogdanov KV; Motorin DV; Nikulina TS; Pisotskaya OS; Babenetskaya DV; Mirolyubova YV; Volkova OY; Zaritskiy AY
Biomed Khim; 2017 Nov; 63(6):570-581. PubMed ID: 29251621
[TBL] [Abstract] [Full Text] [Related]
18. Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 Cases.
Wu B; Ingersoll K; Jug R; Yang LH; Luedke C; Lo A; Su P; Liu X; Rehder C; Gong J; Lu CM; Wang E
Am J Clin Pathol; 2017 Dec; 149(1):55-66. PubMed ID: 29228125
[TBL] [Abstract] [Full Text] [Related]
19.
Calais J; Czernin J; Cao M; Kishan AU; Hegde JV; Shaverdian N; Sandler K; Chu FI; King CR; Steinberg ML; Rauscher I; Schmidt-Hegemann NS; Poeppel T; Hetkamp P; Ceci F; Herrmann K; Fendler WP; Eiber M; Nickols NG
J Nucl Med; 2018 Feb; 59(2):230-237. PubMed ID: 29123013
[TBL] [Abstract] [Full Text] [Related]
20. Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
Dehghan-Nayeri N; Eshghi P; Pour KG; Rezaei-Tavirani M; Omrani MD; Gharehbaghian A
Cancer Chemother Pharmacol; 2017 Jul; 80(1):177-185. PubMed ID: 28585036
[TBL] [Abstract] [Full Text] [Related]
[Next]